Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-021463·ALGER ASSOCIATES INC
Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock · CUSIP: 34962G208
Event date: 2024-12-31
- Filing-level shares
- 1,133,944
- Percent of class
- 17.7%
- Alger Associates, Inc. 13-3017981
Shares: 1,133,944 · Class: 17.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021463
- Form type
- SCHEDULE 13G/A
- Filer
- ALGER ASSOCIATES INC
- CIK
- CIK 1000264
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership